Shikiar Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Hold |
10,750
| – | – | 0.04% | 74 |
|
|
2025
Q1 | $119K | Hold |
10,750
| – | – | 0.04% | 72 |
|
|
2024
Q4 | $114K | Hold |
10,750
| – | – | 0.03% | 74 |
|
|
2024
Q3 | $137K | Hold |
10,750
| – | – | 0.04% | 70 |
|
|
2024
Q2 | $180K | Sell |
10,750
-22,500
| -68% | -$377K | 0.05% | 66 |
|
|
2024
Q1 | $499K | Hold |
33,250
| – | – | 0.15% | 55 |
|
|
2023
Q4 | $499K | Hold |
33,250
| – | – | 0.15% | 50 |
|
|
2023
Q3 | $466K | Hold |
33,250
| – | – | 0.16% | 58 |
|
|
2023
Q2 | $344K | Hold |
33,250
| – | – | 0.11% | 61 |
|
|
2023
Q1 | $307K | Buy |
+33,250
| New | +$307K | 0.11% | 62 |
|
|
2022
Q3 | $277K | Hold |
33,250
| – | – | 0.11% | 69 |
|
|
2022
Q2 | $272K | Hold |
33,250
| – | – | 0.1% | 78 |
|
|
2022
Q1 | $290K | Sell |
33,250
-100
| -0.3% | -$872 | 0.08% | 81 |
|
|
2021
Q4 | $317K | Hold |
33,350
| – | – | 0.08% | 82 |
|
|
2021
Q3 | $561K | Sell |
33,350
-20,000
| -37% | -$336K | 0.16% | 67 |
|
|
2021
Q2 | $815K | Buy |
53,350
+18,000
| +51% | +$275K | 0.23% | 59 |
|
|
2021
Q1 | $689K | Sell |
35,350
-4,600
| -12% | -$89.7K | 0.23% | 59 |
|
|
2020
Q4 | $720K | Sell |
39,950
-4,600
| -10% | -$82.9K | 0.26% | 51 |
|
|
2020
Q3 | $859K | Sell |
44,550
-6,625
| -13% | -$128K | 0.33% | 47 |
|
|
2020
Q2 | $1.34M | Sell |
51,175
-1,375
| -3% | -$35.9K | 0.61% | 34 |
|
|
2020
Q1 | $937K | Sell |
52,550
-14,475
| -22% | -$258K | 0.63% | 32 |
|
|
2019
Q4 | $2.24M | Buy |
67,025
+725
| +1% | +$24.2K | 0.74% | 29 |
|
|
2019
Q3 | $1.58M | Buy |
66,300
+1,800
| +3% | +$42.9K | 0.62% | 33 |
|
|
2019
Q2 | $2.32M | Sell |
64,500
-15,800
| -20% | -$568K | 0.91% | 28 |
|
|
2019
Q1 | $2.97M | Buy |
80,300
+5,850
| +8% | +$216K | 1.24% | 24 |
|
|
2018
Q4 | $3.21M | Sell |
74,450
-3,975
| -5% | -$171K | 1.68% | 20 |
|
|
2018
Q3 | $3.7M | Buy |
78,425
+30,300
| +63% | +$1.43M | 1.44% | 24 |
|
|
2018
Q2 | $2.4M | Buy |
48,125
+2,550
| +6% | +$127K | 1% | 29 |
|
|
2018
Q1 | $2.27M | Buy |
45,575
+24,550
| +117% | +$1.22M | 1.03% | 29 |
|
|
2017
Q4 | $782K | Sell |
21,025
-75
| -0.4% | -$2.79K | 0.37% | 52 |
|
|
2017
Q3 | $665K | Buy |
+21,100
| New | +$665K | 0.29% | 56 |
|